F1000Research · 2018 · 30 citations · 86 references
MedicineOncologyOphthalmologyChemotherapyMolecular OncologyOcular OncologyOcular Surface NeoplasiaOcular TumorsSystemic Therapy For Ocular MalignanciesUveal DiseaseUveal MelanomaCancer/testis Antigen ExpressionIntra-arterial Chemotherapy AdministrationLoss-of-function MutationsMetastatic Risk AssessmentMetastatic Uveal MelanomaUveal Melanoma MetastasisUveal MetastasesVitreous Seeds
<ns4:p>Retinoblastoma and uveal melanoma are the most common intraocular malignancies observed in pediatric and adult populations, respectively. For retinoblastoma, intra-arterial chemotherapy has dramatically improved treatment outcomes and eye salvage rates compared with traditional salvage rates of systemic chemotherapy and external beam radiation therapy. Intravitreal injections of chemotherapy have also demonstrated excellent efficacy for vitreous seeds. Uveal melanoma, on the other hand, is treated predominantly with iodine-125 plaque brachytherapy or with proton beam therapy. Major strides in uveal melanoma genomics have been made since the early 2000s, allowing ocular oncologists to better understand the metastatic risks of the tumor on the basis of specific genetic signatures. Loss-of-function mutations of the<ns4:italic>BAP1</ns4:italic>gene are associated with the highest metastatic risk, whereas gain-of-function mutations of<ns4:italic>SF3B1</ns4:italic>and<ns4:italic>EIF1AX</ns4:italic>often confer a better prognosis. Expression of a cancer-testis antigen called PRAME (preferentially expressed antigen in melanoma) has been shown to increase metastatic risks in both low-risk and high-risk melanomas. New therapeutic approaches, including molecular therapies and nanoparticle phototherapy, are currently being investigated as alternative treatment modalities for uveal melanoma.</ns4:p>
86
Frequent Mutation of <i>BAP1</i> in Metastasizing Uveal Melanomas
J. William Harbour, Michael D. Onken, Elisha Roberson et al. · Science · 2010 · 1.5K citations · Full text
Incidence of noncutaneous melanomas in the U.S.
Colleen C. McLaughlin, Xiao‐Cheng Wu, Ahmedin Jemal et al. · Cancer · 2005 · 732 citations
Medicine, Dermatology, Oncology +12